Vulnerability Details : CVE-2016-8355
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.
Products affected by CVE-2016-8355
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:3.0:*:*:*:*:*:*:*
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:1.0:*:*:*:*:*:*:*
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:2.0:*:*:*:*:*:*:*
- cpe:2.3:a:smiths-medical:cadd-solis_medication_safety_software:3.1:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2016-8355
0.08%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 35 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2016-8355
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
9.0
|
HIGH | AV:N/AC:L/Au:S/C:C/I:C/A:C |
8.0
|
10.0
|
NIST | |
9.9
|
CRITICAL | CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H |
3.1
|
6.0
|
NIST |
CWE ids for CVE-2016-8355
-
The product does not perform any authentication for functionality that requires a provable user identity or consumes a significant amount of resources.Assigned by: nvd@nist.gov (Primary)
References for CVE-2016-8355
-
http://www.securityfocus.com/bid/94630
Smiths-Medical CADD-Solis Medication Safety Software Multiple Security Bypass VulnerabilitiesThird Party Advisory;VDB Entry
-
https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01
Smiths Medical CADD-Solis Medication Safety Software Vulnerabilities | CISAThird Party Advisory;US Government Resource
Jump to